oxfordbiotherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Sitemap: http://www.oxfordbiotherapeutics.com/sitemap.xml User-agent: NerdyBot Disallow: / User-agent: * Disallow: /ajax/ Disallow: /apps/ Disallow: /pipelines.html Disallow: /our-science.html Disallow: /news.html | ||
Meta Tags
| Title | www.oxfordbiotherapeutics.com |
| Description | Harnessing immune cells to cure OxfordBioTherapeutics |
| Keywords | OxfordBioTherapeutics, OGAP, Oxford Biotech, Milton Park |
Server Information
| WebSite | |
| Host IP | 199.34.228.59 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
oxfordbiotherapeutics.com Valuation
|
US$4,859,700
Last updated: 2022-06-21 16:09:05
oxfordbiotherapeutics.com has Semrush global rank of 2,177,975. oxfordbiotherapeutics.com has an estimated worth of US$ 4,859,700, based on its estimated Ads revenue. oxfordbiotherapeutics.com receives approximately 560,735 unique visitors each day. Its web server is located in United States, with IP address 199.34.228.59. According to SiteAdvisor, oxfordbiotherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,859,700 |
| Daily Ads Revenue | US$4,486 |
| Monthly Ads Revenue | US$134,577 |
| Yearly Ads Revenue | US$1,614,916 |
| Daily Unique Visitors | 37,383 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| oxfordbiotherapeutics.com. 7199 | A | oxfordbiotherapeutics.com. 7199 | IP: 199.34.228.59 |
| oxfordbiotherapeutics.com. 86400 IN | NS | NS Record: ns0.phase8.net. | |
| oxfordbiotherapeutics.com. 86400 IN | NS | NS Record: ns2.phase8.net. | |
| oxfordbiotherapeutics.com. 86400 IN | NS | NS Record: ns1.phase8.net. | |
| oxfordbiotherapeutics.com. 86400 IN | MX | MX Record: 0 oxfordbiotherapeutics.com.2.0001.arsmtp.com. | |
| oxfordbiotherapeutics.com. 3600 | MX | oxfordbiotherapeutics.com. 3600 | MX Record: 10 oxfordbiotherapeutics.com.1.0001.arsmtp.com. |
| oxfordbiotherapeutics.com. 86400 IN | TXT | TXT Record: google-site-verification=r2fIP3V5ZhnVMmU8oXugbT_15aGkOPMH1ItzI-5Wbhw | |
| oxfordbiotherapeutics.com. 86400 IN | TXT | TXT Record: v=spf1 include:edgepilot.com include:spf.protection.outlook.com -all | |
| oxfordbiotherapeutics.com. 86400 IN | TXT | TXT Record: MS=ms83086230 |
HtmlToTextCheckTime:2022-06-21 16:09:05
| ABOUT OUR TEAM BOARD OF DIRECTORS INVESTORS OFFICES & LABS PIPELINES INTERNAL PROGRAMS PARTNERED PROGRAMS PARTNERSHIPS OUR SCIENCE IO DISCOVERY PLATFORM > IMMUNE CHECKPOINT TARGETS IO ANTIBODY ENGINEERING OGAP DISCOVERY PLATFORM CAREERS NEWS PRESS RELEASES CONTACT Harnessing immune cells to cure cancer Redefining the cancer-immune synapse for novel immune checkpoint mechanisms NOVEL IO DISCOVERIES Pipelines Immunotherapies for Cancer Oxford BioTherapeutics (OBT) is a clinical stage oncology company focussed only on first-in-class immune therapies, with special emphasis on improving outcomes for patients with solid tumors who respond poorly to PD-1 inhibitors. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. OBT076’s dual mechanism of action allows it to act as a ’primer’ to re-engage the patient’s immune system while at the same time targeting cancer cells directly. Our clinical and pre-clinical pipeline of novel immunotherapies is |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sat, 23 Oct 2021 18:12:56 GMT Server: Apache Location: http://www.oxfordbiotherapeutics.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Sat, 23 Oct 2021 18:12:56 GMT Server: Apache Set-Cookie: is_mobile=0; path=/; domain=www.oxfordbiotherapeutics.com Vary: X-W-SSL,Accept-Encoding,User-Agent Set-Cookie: language=en; expires=Sat, 06-Nov-2021 18:12:56 GMT; Max-Age=1209600; path=/ Cache-Control: private ETag: W/"3707e6bb4457be785a0151beb2790412" X-Host: pages8.sf2p.intern.weebly.net X-UA-Compatible: IE=edge,chrome=1 Content-Type: text/html; charset=UTF-8 |
oxfordbiotherapeutics.com Whois Information
Domain Name: OXFORDBIOTHERAPEUTICS.COM Registry Domain ID: 1514892813_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.register.it Registrar URL: http://www.register.it Updated Date: 2014-09-05T15:00:17Z Creation Date: 2008-08-19T13:44:10Z Registry Expiry Date: 2024-08-19T13:44:10Z Registrar: Register SPA Registrar IANA ID: 168 Registrar Abuse Contact Email: abuse@register.it Registrar Abuse Contact Phone: +39.05520021555 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS0.PHASE8.NET Name Server: NS1.PHASE8.NET Name Server: NS2.PHASE8.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T04:12:34Z <<< |